000 | 01723 a2200577 4500 | ||
---|---|---|---|
005 | 20250518060043.0 | ||
264 | 0 | _c20200828 | |
008 | 202008s 0 0 eng d | ||
022 | _a1873-2496 | ||
024 | 7 |
_a10.1016/j.urolonc.2019.08.001 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRichters, A | |
245 | 0 | 0 |
_aBladder cancer survival: Women only fare worse in the first two years after diagnosis. _h[electronic resource] |
260 |
_bUrologic oncology _c12 2019 |
||
300 |
_a853-861 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Observational Study | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aCystectomy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoadjuvant Therapy |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aNetherlands _xepidemiology |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aRegistries _xstatistics & numerical data |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSex Factors |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aUrinary Bladder _xpathology |
650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xmortality |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aDickman, P W | |
700 | 1 | _aWitjes, J A | |
700 | 1 | _aBoormans, J L | |
700 | 1 | _aKiemeney, L A L M | |
700 | 1 | _aAben, K K H | |
773 | 0 |
_tUrologic oncology _gvol. 37 _gno. 12 _gp. 853-861 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.urolonc.2019.08.001 _zAvailable from publisher's website |
999 |
_c30072963 _d30072963 |